Latest filing published 05 Apr 2022 for C4 Therapeutics, Inc., €9,354.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Alain J. Cohen, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Opnet Technologies Inc and C4 Therapeutics, Inc. In total, 68 filings cover trades dated from 6 February 2006 to 4 April 2022.
The open-market side counts 7 purchases for €339k alongside 20 sales for €1.0M. The net balance comes to €707k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 24 share grants and 10 option exercises.
Half of the purchases are above €52k and half below.
The latest filing, published on 5 April 2022, reports a share grant of €9,354 in C4 Therapeutics, Inc. The clock since the last published purchase (23 November 2007) now reads 6,910 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations